ANIX Anixa Biosciences Inc

USD 2.62 -0.05 -1.872659
Icon

Anixa Biosciences Inc (ANIX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.62

-0.05 (-1.87)%

USD 0.09B

0.09M

USD 9.50(+262.60%)

N/A

Icon

ANIX

Anixa Biosciences Inc (USD)
COMMON STOCK | NSD
USD 2.62
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.09B

N/A

USD 2.62

Anixa Biosciences Inc (ANIX) Stock Forecast

Show ratings and price targets of :
USD 9.50
(+262.60%)

Based on the Anixa Biosciences Inc stock forecast from 1 analysts, the average analyst target price for Anixa Biosciences Inc is USD 9.50 over the next 12 months. Anixa Biosciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Anixa Biosciences Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Anixa Biosciences Inc’s stock price was USD 2.62. Anixa Biosciences Inc’s stock price has changed by +2.75% over the past week, -12.67% over the past month and -23.39% over the last year.

No recent analyst target price found for Anixa Biosciences Inc
No recent average analyst rating found for Anixa Biosciences Inc

Company Overview Anixa Biosciences Inc

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chi...Read More

https://www.anixa.com

3150 Almaden Expressway, San Jose, CA, United States, 95118

4

October

USD

USA

Adjusted Closing Price for Anixa Biosciences Inc (ANIX)

Loading...

Unadjusted Closing Price for Anixa Biosciences Inc (ANIX)

Loading...

Share Trading Volume for Anixa Biosciences Inc Shares

Loading...

Compare Performance of Anixa Biosciences Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ANIX

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Anixa Biosciences Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.75 (-0.36%) USD124.65B 31.35 20.00

ETFs Containing ANIX

Symbol Name ANIX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Anixa Biosciences Inc (ANIX) Stock

Based on ratings from 1 analysts Anixa Biosciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on ANIX's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for ANIX is USD 9.50 over the next 12 months. The maximum analyst target price is USD 12 while the minimum anlayst target price is USD 7.

Unfortunately we do not have enough data on ANIX's stock to indicate if its overvalued.

The last closing price of ANIX's stock was USD 2.62.

The most recent market capitalization for ANIX is USD 0.09B.

Based on targets from 1 analysts, the average taret price for ANIX is projected at USD 9.50 over the next 12 months. This means that ANIX's stock price may go up by +262.60% over the next 12 months.

We can't find any ETFs which contains Anixa Biosciences Inc's stock.

As per our most recent records Anixa Biosciences Inc has 4 Employees.

Anixa Biosciences Inc's registered address is 3150 Almaden Expressway, San Jose, CA, United States, 95118. You can get more information about it from Anixa Biosciences Inc's website at https://www.anixa.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...